4/A

PRIMARY DOCUMENT

Company: GALECTIN THERAPEUTICS INC
Filed: December 8, 2017
Period of Report: December 8, 2017
Accession Number: 0001179022-17-000071

View Document ↗ View on SEC.gov ↗